ClinicalTrials.gg
CompletedNCT03332381Updated Nov 6, 2017

Attention Training Technique and Mindful Self-Compassion

An interventional study of Attention training technique and Mindful self-compassion in Anxiety, Depression and Stress, Psychological, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-11-06.

Primary conditionDepressionRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Depression
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Depression.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 5 months after the study started (first participant enrolled May 2015, registered Oct 2017).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
81
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 109 studies in Depression with a site in Norway — 22 open to participants now, 31 under way, none of them phase 3. Depression · Norway.

Enrollment
55th of 81
81 · median 170
Started
2015
with 4 others
No phase
66 of 109
16 open now
Registered
47th of 109
by date
Lead sponsor
7 of 109
Norwegian University of Science and Technology

Among the 109 studies in Depression with a site in Norway, this one is the 55th largest by enrollment of the 81 interventional ones that give a count, is one of 5 that started in 2015, is one of 66 with no phase, and was the 47th registered.

Depression

8,582 studies on the registry are indexed under Depression; 1,723 are open to participants now.

Browse Depression studies →

Open to participants now

22 of the 109 studies in Depression with a site in Norway are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →

Who these studies take

Of the 1,089 Depression studies recruiting now, 470 (43%) set no upper age limit and 519 (48%) stop at 75 or younger; 203 take children under 18; 311 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 109 studies in Depression with a site in Norway, or all of them as a file.
02

Study summary

The design of the study is a randomized controlled trial. A total of 80 students with self-reported symptoms of stress/anxiety/depression will be invited to take part in a 3-session course consisting of either attention training or self-compassion/mindfulness based meditation. Attention training involves modifying metacognitive control and enhancing attention flexibility so that people can refrain from responding to intrusions with extended processing. Self-compassion involves not avoiding painful or distressing feelings. Instead these experiences are held in awareness with kindness, understanding, and a sense of shared humanity.

03

Conditions studied

  • Anxiety
  • Depression
  • Stress, Psychological

Browse trials for

04

In context

Depression Reclassified

8,582 studies on the registry are indexed under Depression; 1,723 are open to participants now.

This study's enrollment of 81 is close to the median of 81 across 7,066 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 495 studies on the registry; 48 are open to participants now.

Compared within Depression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • self reported symptoms of stress/anxiety/depression

Exclusion criteria

Exclusion Criteria:

-

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
81 participants (actual)

Study arms

  • Active comparator
    Attention training technique

    Behavioral: Attention training technique

  • Active comparator
    Mindful self-compassion

    Behavioral: Mindful self-compassion

Interventions

  • BehavioralAttention training technique

    Attention training involves modifying metacognitive control and enhancing attention flexibility so that people can refrain from responding to intrusions with extended processing.

    Also known as: ATT

  • BehavioralMindful self-compassion

    Self-compassion involves not avoiding painful or distressing feelings. Instead these experiences are held in awareness with kindness, understanding, and a sense of shared humanity.

    Also known as: MSC

07

What researchers measure

Primary outcomes

  1. Change in symptoms of depression as assessed with the Patient Health Questionnaire-9

    Assesses symptoms of depression. Total score range from 0 (no depression) to 27 (very depressed). Lower values represent better outcome. Subscale scores are not used.

    Time frame: Baseline, immediately after last session, 6 months after intervention

  2. Change in symptoms of anxiety as assessed with the Generalized Anxiety Disorder-7 scale

    Assesses symptoms of anxiety. Total score range from 0 (no depression) to 21 (very depressed). Lower values represent better outcome. Subscale scores are not used.

    Time frame: Baseline, immediately after last session, 6 months after intervention

Secondary outcomes

  1. Changes in self-compassion as assessed by the Self-Compassion Scale Short Form

    Assessment of self-compassion. Total score range from 12 (no self-compassion) to 60 (high on self-compassion). Higher values represent better outcome. Subscale scores are not used.

    Time frame: Baseline, immediately after last session, 6 months after intervention

  2. Changes in the attention flexibility subscale of the Detached Mindfulness Questionnaire

    Assessment of attention flexibility. Total score for attention flexibility range from 5 (no flexibility) to 25 (very flexible). Higher values represent better outcome. No other subscales are used.

    Time frame: Baseline, immediately after last session, 6 months after intervention

  3. Changes in mindfulness as assessed with The Five Facet Mindfulness Questionnaire

    Assessment of mindfulness. Total score range from 20 (not mindful at all) to 100(very mindful). Higher values represent better outcome. Subscale scores are not analyzed.

    Time frame: Baseline, immediately after last session, 6 months after intervention

08

Study locations

1 site
  • Psykologisk Institutt, Dragvoll
    Trondheim, 7491, Norway
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2015 to primary completion in May 2017, 24 months.

Of 3,471 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 24 months is above that.

Counting every sponsor, half of 3,569 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2017
First posted
Nov 6, 2017
StartActual
May 1, 2015
Primary completionActual
May 1, 2017
CompletionActual
Sep 1, 2017
Last update
Nov 6, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 6, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03332381
Responsible party
Sponsor
First posted
Nov 6, 2017
Start date
May 1, 2015
Primary completion
May 1, 2017
Completion
Sep 1, 2017
Last update
Nov 6, 2017

Study contacts

Magne Flaten, phd
study director · Norwegian University of Science and Technology

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion